Nicoya has secured $10 million in Series A financing through Toronto-based Whitecap Venture Partners, along with Garage Capital, MaRS Investment Accelerator Fund, the Laurier Startup Fund, the University of Waterloo Student Venture Fund, and others. Nicoya's product, OpenSPR, is a nanotechnology-enabled biosensor that measures how molecules interact in real time and gives scientists and researchers far more insight into how diseases work, allowing them to design and develop better treatments.

Jan 14, 2020

Kitchener medical technology firm Nicoya secures $10 million in funding

Nanox is bringing nanotechnology to medical imaging and hoping to expand access to healthcare at the same time.

The Israeli company is developing the Nanox.ARC and Nanox.CLOUD, a X-ray system that can take a full-body scan and then send the image to the cloud. The fully digital X-ray machine updates technology that was first discovered in 1895 by German physicist, Wilhelm Conrad Röntgen, who won the first Nobel Prize in physics for his discovery of X-rays.

Jan 17th, 2020

Israeli company modernizes X-ray machines with nanotechnology

The investment round was led by Imec.Xpand, the independent venture capital arm of Imec that specializes in hardware and nanotechnology out of the innovation hub. Additional support comes from Fidimec, which focuses on seed investments for startups, and the Flanders investment company PMV.

Jan 9th, 2020

Imec spinoff perceives 4.5 million for microLEDs in AR glasses

We use nanotechnology to try to increase the viability of vitamins A, D and E or other healthy ingredients in food, like carrots and peppers, that often have low viability,” McClements said in a recent interview. “Only a little gets absorbed by the human body and we are trying to design food matrix to increase the amount absorbed by the body.

Jan 07 2020

Designing healthier foods — particle by particle: UMass scientist works at the nanoscale to fortify foods with vitamins and probiotics

Biotech company Emergex Vaccines Holding Limited has raised over $11 million in a Series A round led by Singapore-based venture capital firm Vickers Venture Partners, according to a statement. Founded in 2016, Emergex, a UK-based biotechnology company, claims to have developed vaccines to address some of the world’s most immediate health threats such as Dengue Fever, Zika, Ebola, pandemic flu and serious intra-cellular bacterial infections.

Jan 09 2020

SG’s Vickers Venture leads $11m funding in biotech firm Emergex Vaccines

Imbed Biosciences Inc., a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, has closed its Series A Preferred Stock equity financing, which was expanded to $4 million due to investor demand. The funding will be used to commercialize the company’s FDA-cleared Microlyte Matrix wound dressing indicated for the management of chronic ulcers, burns, and surgical wounds. Microlyte Matrix is an ultrathin bandage made with bioresorbable polymers and a patented antimicrobial silver nanotechnology.

Dec 14 2019

Business Briefs: Imbed Biosciences Extends Series A Financing to $4M

The Fortum-Rusnano wind power investment fund has announced it has taken the investment decision to launch a 50 MW wind farm project in the Russian region of Rostov.
Fortum-Rusnano, a 50/50 partnership between Finnish utility Fortum Oyj (HEL:FORTUM) and Russian nanotechnology company Rusnano, won 1,823 MW of wind power capacity in Russia’s wind auctions held in 2017 and 2018. This 50 MW project is the partnership’s fifth of the awarded lot.

Dec 12 2019

Wind energy in Russia, Fortum, Rusnano to go ahead with 50 MW wind farm

BioConnect is pleased to announce our new innovation hub, BioConnect Labs. For the past decade, BioConnect has been a leader in creating world-class biometric solutions for over 900 customers and 60 partnerships. Our mission is to enable trust in the connected world – using biometrics to secure people, spaces, and digital transactions for the companies we serve. BioConnect Labs has been 2 years in the making, backed by our customers and supported by Canadian FedDev investment of 3.9 Million dollars.

Nov 26 2019

BioConnect Announces New Innovation Initiative – BioConnect Labs

The Los Angeles-based company leverages advanced carbon research conducted at UCLA, KACST and USC and is backed by a $5.5 million investment from TAQNIA International. Carbonics intends to incorporate carbon nanomaterials into semiconductor radio frequency (RF) components to reduce battery demands and increase device efficiency.

Nov 19 2019

Carbonics, Inc. launches with $5.5M investment